P1007: SPLENOMEGALY DEVELOPMENT PRECEDES THE PROGRESS OF HEMATOPOIETIC STEM CELLS MIGRATION TO SPLEEN IN MURINE MYELOFIBROSIS MODELS

P1007: SPLENOMEGALY DEVELOPMENT PRECEDES THE PROGRESS OF HEMATOPOIETIC STEM CELLS MIGRATION TO SPLEEN IN MURINE MYELOFIBROSIS MODELS

Bibliographic Details
Main Authors:	Toshikuni Kawamura, Takaaki Maekawa, Hiraku Ogata, Noriaki Tachi, Shoichiro Kato, Yukiko Osawa, Takahiro Einama, Shinichi Kobayashi, Fumihiko Kimura
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970932.09951.a9

Similar Items

Multifocal Sclerosing Angiomatoid Nodular Transformation of the Spleen With Splenomegaly and Thrombocytopenia
by: Chendong He, et al.
Published: (2022-01-01)

P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS
by: J.-J. Kiladjian, et al.
Published: (2022-06-01)

Splenomegaly in children with sickle cell disease-does spleen regress or persist?
by: Sunil Jondhale, et al.
Published: (2022-01-01)

Large epidermoid cyst of the spleen causing massive splenomegaly: A case report
by: Deshan Mario Gomez, et al.
Published: (2024-03-01)

Single port laparoscopic splenectomy for wandering spleen with splenomegaly in a patient with Wolf-Hirschhorn syndrome
by: Ricardo Zorron, et al.
Published: (2017-01-01)

The Compensation for Spleen: a Criticism of the Precedent of the Supreme Court
by: Ruhollah Akrami
Published: (2015-12-01)

P1039: PALPABLE SPLEEN SIZE IS PROGNOSTIC IN PRIMARY BUT NOT SECONDARY MYELOFIBROSIS
by: M. Lucijanic, et al.
Published: (2022-06-01)

P1037: CONSISTENCY OF PACRITINIB FOR SPLEEN AND SYMPTOM REDUCTION IN PATIENTS WITH MYELOFIBROSIS REGARDLESS OF CYTOPENIAS
by: Nico Gagelmann, et al.
Published: (2023-08-01)

Outcome of pregnancy in women with splenomegaly
by: AbdelAziem A. Ali, et al.
Published: (2023-03-01)

Gastric leiomyosarcoma mimicking splenomegaly
by: Samuel O C. Emedike, et al.
Published: (2001-01-01)

Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression
by: Alessandro Malara, et al.
Published: (2022-09-01)

Early Ultrasound Signs of Splenomegaly in Neonates
by: S. A. Perepelitsa, et al.
Published: (2019-09-01)

P982: MYELOID-DERIVED SUPPRESSOR CELLS: CHARACTERIZATION IN PERIPHERAL BLOOD AND SPLEEN TISSUE OF PATIENTS WITH MYELOFIBROSIS
by: R. Campanelli, et al.
Published: (2022-06-01)

Reduction of spleen size in a child with Hyperreactive Malarious Splenomegaly (HMS) treated outside the Brazilian endemic area of malaria with only one course of quinine
by: Maria Imaculada Muniz-Junqueira, et al.
Published: (1992-12-01)

Nosological aspects of hepatomegaly and splenomegaly at pediatric age
by: M. M. Kotovich, et al.
Published: (2016-08-01)

Gaucher Disease: A Case with Unexplained Splenomegaly
by: Ahsan Ahmad Alvi , Ayesha Nayyar , Rabiah Asghar , Muhammad Nadeem Akbar Khan , Ayesha Elahi , Ammar Naqvi
Published: (2018-03-01)

Trichobezoar masquerading as massive splenomegaly: Rapunzel’s syndrome revisited
by: Zhi, Alex Yang Koh, et al.
Published: (2022)

Giant left lobe hemangioma of the liver misdiagnosed for splenomegaly
by: Tošković Borislav, et al.
Published: (2023-01-01)

Hepatomegaly and Splenomegaly: An Approach to the Diagnosis of Lysosomal Storage Diseases
by: Teodoro Jerves Serrano, et al.
Published: (2024-03-01)

P1036: VOLUMETRIC SPLENOMEGALY IN PATIENTS WITH POLYCYTHEMIA VERA
by: M.-W. Lee, et al.
Published: (2022-06-01)

Massive Splenomegaly: A Rare Presentation of Megaloblastic Anemia
by: Tahereh Gholipour, et al.
Published: (2021-04-01)

Gaucher Disease: One of the Few Causes of Massive Splenomegaly
by: Magda Garça, et al.
Published: (2022-12-01)

TEMPORARY REMOVAL: Tropical splenomegaly in a migrant-in-transit crossing the Darien gap, Panamá: A probable case of hyper-reactive malarial splenomegaly
by: Mónica R.A. Pachar-Flores, et al.
Published: (2023-01-01)

Investigation of familial segregation of hyperreactive malarial splenomegaly in Kumasi, Ghana.
by: Martin-Peprah, R, et al.
Published: (2006)

Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma
by: Gianluca Bossù, et al.
Published: (2023-05-01)

A questão das esplenomegalias mycosicas The question of mycotic splenomegaly
by: Olympio da Fonseca Filho, et al.
Published: (1928-01-01)

Treatment of suspected hyper-reactive malarial splenomegaly (HMS) in pregnancy with mefloquine.
by: Jaroensuk, J, et al.
Published: (2014)

Treatment of suspected hyper-reactive malarial splenomegaly (HMS) in pregnancy with mefloquine.
by: Jaroensuk, J, et al.
Published: (2014)

Two-Stage Deep Learning Model for Automated Segmentation and Classification of Splenomegaly
by: Aymen Meddeb, et al.
Published: (2022-11-01)

Anesthetic-surgical procedure in an adult with splenomegaly due to primary spleenic lymphoma
by: Karell Piñón García, et al.
Published: (2023-02-01)

Streptococcus suis Serotype 2 Infection Induces Splenomegaly with Splenocyte Apoptosis
by: Shujie Wang, et al.
Published: (2022-12-01)

Serial magnetic resonance imaging of splenomegaly in the Trypanosoma brucei infected mouse.
by: Samantha Paterson, et al.
Published: (2022-12-01)

A case of resistant malarial infection with hyper reactive malarial splenomegaly
by: P K Singh, et al.
Published: (2015-01-01)

Serial magnetic resonance imaging of splenomegaly in the Trypanosoma brucei infected mouse
by: Samantha Paterson, et al.
Published: (2022-12-01)

P1061: INDIRECT TREATMENT COMPARISONS OF FEDRATINIB VERSUS NAVITOCLAX PLUS RUXOLITINIB: EFFECT ON SPLEEN VOLUME AND SYMPTOMS IN RUXOLITINIB-EXPOSED MYELOFIBROSIS PATIENTS
by: P. Abraham, et al.
Published: (2022-06-01)

The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis
by: Heather R. Wolfe, et al.
Published: (2022-04-01)

P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFIBROSIS PATIENTS ON PACRITINIB BUT NOT BEST AVAILABLE THERAPY: PERSIST-2 LANDMARK OVERALL SURVIVAL ANALYSIS
by: Jan Bewersdorf, et al.
Published: (2023-08-01)

Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT
by: Jih-An Cheng, et al.
Published: (2023-12-01)

Loss of PKGIβ/IRAG1 Signaling Causes Anemia-Associated Splenomegaly
by: Michael Majer, et al.
Published: (2021-05-01)

Multiple hepatic and osseous focal lesions without splenomegaly and/or lymph nodes enlargement
by: Maged T. Elghannam, et al.
Published: (2023-02-01)